These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7700966)

  • 1. Development of biologically-controlled insulin pumps with glucose-dependent release.
    Gröning R; Walz C
    Pharmazie; 1995 Feb; 50(2):128-9. PubMed ID: 7700966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin pumps and glucose regulation.
    Thompson JS; Duckworth WC
    World J Surg; 2001 Apr; 25(4):523-6. PubMed ID: 11344407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An artificial endocrine pancreas--problems awaiting solution for long-term clinical applications of a glucose sensor.
    Shichiri M; Fukushima H; Sakakida M; Kajiwara K; Hashiguchi Y
    Front Med Biol Eng; 1991; 3(4):283-92. PubMed ID: 1799562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From external to implantable insulin pump, can we close the loop?].
    Renard E; Costalat G; Bringer J
    Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autonomous drug release system based on chemo-mechanical energy conversion "Organic Engine" for feedback control of blood glucose.
    Kato R; Munkhjargal M; Takahashi D; Arakawa T; Kudo H; Mitsubayashi K
    Biosens Bioelectron; 2010 Dec; 26(4):1455-9. PubMed ID: 20728337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose monitoring and closed-loop systems.
    Hovorka R
    Diabet Med; 2006 Jan; 23(1):1-12. PubMed ID: 16409558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in biosensor for measurement of glucose concentration].
    Shichiri M; Nishida K; Sakakida M
    Nihon Rinsho; 1997 Nov; 55 Suppl():799-804. PubMed ID: 9434567
    [No Abstract]   [Full Text] [Related]  

  • 8. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Artificial and bioartificial pancreas for the treatment of diabetes mellitus].
    Reach G
    Diabete Metab; 1994; 20(2 Pt 2):183-93. PubMed ID: 8001705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.
    Bevier WC; Zisser H; Palerm CC; Finan DA; Seborg DE; Doyle FJ; Wollitzer AO; Jovanovic L
    Diabetes Metab Res Rev; 2007 Sep; 23(6):472-8. PubMed ID: 17315240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New concepts and applications in the use of the insulin pump during pregnancy.
    Gabbe SG
    J Matern Fetal Med; 2000; 9(1):42-5. PubMed ID: 10757434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin therapy by insulin pump: continuous or conventional self-blood glucose monitoring? ].
    Renard E
    Diabetes Metab; 2003 Apr; 29(2 Pt 2):S54-62. PubMed ID: 12746628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin infusion induces endothelin-1-dependent hypertension in rats.
    Juan CC; Shen YW; Chien Y; Lin YJ; Chang SF; Ho LT
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E948-54. PubMed ID: 15226099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulfilling the promise of insulin pump therapy in childhood diabetes.
    Tamborlane WV
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant hyperkalemia after discontinuation of an insulin pump.
    Groudine SB; Phan B
    J Clin Anesth; 2005 Dec; 17(8):630-2. PubMed ID: 16427537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivative weighted active insulin control modelling and clinical trials for ICU patients.
    Doran CV; Hudson NH; Moorhead KT; Chase JG; Shaw GM; Hann CE
    Med Eng Phys; 2004 Dec; 26(10):855-66. PubMed ID: 15567701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable insulin pumps. A position statement about their clinical use.
    Renard E; Schaepelynck-Bélicar P;
    Diabetes Metab; 2007 Apr; 33(2):158-66. PubMed ID: 17300973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.